INFLECTIS BIOSCIENCE
🏢 View company profile →8Patents
8Active
8Granted
44Portfolio score
Filing activity: Jan 10, 2014 → Dec 2, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9682943B2 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | Chemistry; Metallurgy | 5 | Active |
| US10526297B2 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | Chemistry; Metallurgy | 1 | Active |
| US10100020B2 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | Chemistry; Metallurgy | 1 | Active |
| US10954198B2 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | Chemistry; Metallurgy | 0 | Active |
| US10544093B2 | O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins | Chemistry; Metallurgy | 0 | Active |
| US11084783B2 | O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteins | Chemistry; Metallurgy | 0 | Active |
| US10709677B2 | Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies | Emerging Cross-Sectional Technologies | 0 | Active |
| US10675257B2 | Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agent | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.